Covid-19 Testing
Geneblitz® is the molecular biology services division of Complement Genomics Ltd. and is based at the prestigious Durham Genome Centre, Lanchester, County Durham, UK.
The company serves corporate clients (pharma, CROs) with services in genotyping (drug metabolism), next-generation sequencing (NGS), gene expression analysis, dPCR, biomarker analysis (ELISA, biochemical assays), bio-banking, human identity testing and nucleic acid based microbial analysis. We offer Covid-19 PCR testing to business clients, laboratory and equipment validation services and absolute quantification of SARS- Cov-2 by dPCR for drug development projects.
If you require genetic analysis in phase I – IV trials, please contact us – we have been providing genotype data on drug metabolising enzymes for many years and we have an experienced team of molecular biologists working to ISO 17025 and GCP, ready to support you.
Our services
We're Experts in Biomarker Analysis
Our genotyping service offers an extensive range of assays designed to complement drug.
Our genotyping service offers an extensive range of assays designed to complement drug discovery, research and clinical trial programmes.
We conduct studies at all levels of the biomarker hierarchy, including DNA, mRNA, protein levels or small molecule level. We specialise in biomarker qualification and validation.
We conduct Next Generation Sequencing (NGS) for, inter alia, whole exome, whole genome, RNAseq and mitochondrial genomes.
Using Next Generation Sequencing (NGS) we offer microbiome analysis for bacterial (16S) and fungal (ITS1, ITS2) populations from any sample type.
Maintaining the highest possible sample integrity while working to GCP is the sole focus of all biological samples in our biobank.